Ftse Mib
33.943,29
-1,33%
DAX
20.004,08
-1,27%
S&P 500
5.872,16
-2,95%
NASDAQ
19.392,69
-3,56%
Bitcoin
102.316,51
2,25%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aethlon Medical Inc (AEMD) Aethlon Medical Inc (AEMD) Notizie

AEMD

Aethlon Medical (AEMD)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AEMD
DataOraFonteTitoloSimboloCompagnia
15/11/202422:40Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AEMDAethlon Medical Inc
13/11/202423:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AEMDAethlon Medical Inc
13/11/202422:15PR Newswire (US)Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
12/11/202415:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
11/11/202414:01PR Newswire (US)Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in AustraliaNASDAQ:AEMDAethlon Medical Inc
06/11/202414:01PR Newswire (US)Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024NASDAQ:AEMDAethlon Medical Inc
08/10/202414:01PR Newswire (US)Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:AEMDAethlon Medical Inc
01/10/202423:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
19/09/202414:01PR Newswire (US)Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in IndiaNASDAQ:AEMDAethlon Medical Inc
16/09/202414:01PR Newswire (US)Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer TrialNASDAQ:AEMDAethlon Medical Inc
13/09/202414:35GlobeNewswire Inc.Aethlon Medical to Present at the Life Sciences Investor Forum September 19thNASDAQ:AEMDAethlon Medical Inc
27/08/202414:01PR Newswire (US)Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor KidneysNASDAQ:AEMDAethlon Medical Inc
15/08/202422:34Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AEMDAethlon Medical Inc
15/08/202422:32Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AEMDAethlon Medical Inc
15/08/202422:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AEMDAethlon Medical Inc
15/08/202422:15Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:AEMDAethlon Medical Inc
14/08/202422:15PR Newswire (US)Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
12/08/202414:01PR Newswire (US)Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer TrialNASDAQ:AEMDAethlon Medical Inc
06/08/202415:12PR Newswire (US)Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024NASDAQ:AEMDAethlon Medical Inc
27/06/202422:15PR Newswire (US)Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
21/06/202414:01PR Newswire (US)Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024NASDAQ:AEMDAethlon Medical Inc
18/06/202414:01PR Newswire (US)Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer TrialNASDAQ:AEMDAethlon Medical Inc
03/06/202414:01PR Newswire (US)Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment StudiesNASDAQ:AEMDAethlon Medical Inc
17/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEMDAethlon Medical Inc
16/05/202422:05Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:AEMDAethlon Medical Inc
15/05/202415:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AEMDAethlon Medical Inc
15/05/202415:15PR Newswire (US)Aethlon Medical Announces Pricing of $4.7 Million Public OfferingNASDAQ:AEMDAethlon Medical Inc
13/05/202423:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AEMDAethlon Medical Inc
10/05/202414:01PR Newswire (US)Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient PlasmaNASDAQ:AEMDAethlon Medical Inc
21/02/202414:01PR Newswire (US)Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture DevicesNASDAQ:AEMDAethlon Medical Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AEMD

La tua Cronologia

BIT
TIT
Telecom Italia
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
UCG
Unicredit
BIT
SPM
Saipem
BIT
RACE
Ferrari NV
BIT
NEXI
Nexi S.p.A
BIT
BAMI
Banco BPM
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SES
Sesa
BIT
SRG
Snam
BIT
TRN
Terna Trasmissione Elett...
BIT
BPE
Bper Banca
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network